| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,565 |
2,309 |
$259K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,778 |
1,654 |
$239K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
306 |
303 |
$41K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
183 |
182 |
$25K |
| 80050 |
General health panel |
454 |
454 |
$20K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
854 |
847 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
131 |
131 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
278 |
275 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
516 |
503 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
210 |
207 |
$7K |
| 80061 |
Lipid panel |
473 |
471 |
$6K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
68 |
68 |
$5K |
| 87070 |
|
394 |
387 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
351 |
351 |
$3K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
25 |
25 |
$3K |
| 99215 |
Prolong outpt/office vis |
16 |
13 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
68 |
68 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
36 |
36 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
36 |
36 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$949.48 |
| 87634 |
|
13 |
12 |
$912.60 |
| 96127 |
|
130 |
129 |
$850.23 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
66 |
65 |
$547.48 |
| 80053 |
Comprehensive metabolic panel |
34 |
34 |
$399.16 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
13 |
$384.80 |
| 36415 |
Collection of venous blood by venipuncture |
352 |
348 |
$373.28 |
| 90686 |
|
340 |
339 |
$265.10 |
| 92551 |
|
129 |
129 |
$176.20 |
| 87420 |
|
12 |
12 |
$166.92 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
14 |
$129.12 |
| 96160 |
|
71 |
71 |
$89.93 |
| 85652 |
|
13 |
12 |
$39.00 |
| 99173 |
|
120 |
120 |
$3.81 |
| 36416 |
|
12 |
12 |
$0.00 |